Cargando…
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Drug resistance represents a major obstacle in cancer management, and the mechanisms underlying stress adaptation of cancer cells in response to therapy-induced hostile environment are largely unknown. As the central organelle for cellular energy supply, mitochondria can rapidly undergo dynamic chan...
Autores principales: | Jin, Ping, Jiang, Jingwen, Zhou, Li, Huang, Zhao, Nice, Edouard C., Huang, Canhua, Fu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290242/ https://www.ncbi.nlm.nih.gov/pubmed/35851420 http://dx.doi.org/10.1186/s13045-022-01313-4 |
Ejemplares similares
-
A cellular thermal shift assay for detecting amino acid sites involved in drug target engagement
por: Peng, Liyuan, et al.
Publicado: (2022) -
Protein degradation: expanding the toolbox to restrain cancer drug resistance
por: Ming, Hui, et al.
Publicado: (2023) -
Cancer drug resistance: redox resetting renders a way
por: Liu, Yuan, et al.
Publicado: (2016) -
Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy
por: Jiang, Jingwen, et al.
Publicado: (2017) -
Overcoming cancer therapeutic bottleneck by drug repurposing
por: Zhang, Zhe, et al.
Publicado: (2020)